Discussing the early trial results of the next-generation cholesterol lowering drugs, with Tony Butler, Barclay's managing director/pharmaceuticals analyst.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT